Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to ...
CPAM serves as a resource dedicated to helping UAB researchers understand genetic changes in disease by developing precision disease models that span experimental, cellular and computational systems. ...
Medical imaging foundation models are ushering in a new era for precision oncology. By integrating massive multimodal datasets and advanced AI algorithms, these models achieve unprecedented accuracy ...
Cancer immunotherapy has significantly changed the clinical management of multiple malignancies, yet substantial challenges remain in identifying which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results